Live symbol workspace

JNJ market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $243.04

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$230.89

Resistance

$255.19

Volume & Momentum

Volume

Normal

1.0x avg

Momentum

0%

Weak

Technical Context

Current price

$243.04

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for JNJ skewed neutral (5 of 6 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

31%

▼ 2.9 pts vs previous week

Avg confidence across 39 calls in the last 7 days

What sources say

Neutral 5 articles

Ebola Crisis Exposes Congo's Fragile Health System

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?

Why Is JNJ Stock Defying The Market’s Daily Mood Swings?

Bearish 1 article

Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

JNJ News Intelligence (24 articles)

AI-curated news influencing JNJ price, sentiment, and trend

Explore All JNJ News with AI Analysis

Economy

5 days, 2 hours ago

Ebola Crisis Exposes Congo's Fragile Health System

Daniele Nyirandutiye, Senior Fellow at the Center for American Progress, discusses how the Ebola outbreak in Congo exposed critical weaknesses …

Impact on JNJ: The Ebola outbreak may lead to increased demand for healthcare services and …

The Ebola crisis in Congo has exposed the country's fragile health system, highlighting the need … Medium (40%)

View full analysis →

Bloomberg 40% confidence

Economy

5 days, 11 hours ago

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?

Compare portfolio concentration, risk profiles, and long-term growth as these two pharma ETFs take different approaches to capturing sector opportunity.

Impact on JNJ: The comparison may lead to a rotation of capital between PPH and …

The article compares VanEck's PPH and Invesco's PJP pharmaceutical ETFs, focusing on portfolio concentration, risk … Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

1 week, 2 days ago

Why Is JNJ Stock Defying The Market’s Daily Mood Swings?

The healthcare giant is making waves, but its true value for investors lies in how little it moves with the …

Impact on JNJ: Neutral market sentiment indicated

Analysis of stock market developments showing neutral sentiment. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

1 week, 4 days ago

These Household Names Are Dividend Kings. They’re Rock-Solid For Income.

Many Kings are household names, like Coke, Pepsi, Johnson & Johnson and Procter & Gamble Over the past decade-plus, they’ve …

Impact on JNJ: The article's focus on dividend kings may lead to increased interest in …

The article highlights dividend kings such as Coke, Pepsi, Johnson & Johnson, and Procter & … Medium (60%)

View full analysis →

Yahoo Finance 60% confidence

Economy

1 week, 6 days ago

Africa CDC Calls for More Ebola Funding

As Ebola cases rise in the Democratic Republic of Congo and Uganda, Africa CDC's Director General Jean Kaseya says more …

Impact on JNJ: The news may lead to increased investment in healthcare and pharmaceutical stocks, …

The Africa CDC is calling for increased funding to combat the rising Ebola cases in … Medium (50%)

View full analysis →

Bloomberg 50% confidence

Economy

3 weeks ago

Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook

Pfizer’s recent drug approvals give the company something to build on, with shareholders looking for evidence that cost cuts and …

Impact on JNJ: Pfizer's stock price (PFE) may decline due to the CFO transition, potentially …

Pfizer's CFO transition has sparked concerns about the company's ability to meet its 2026 earnings … High (70%)

View full analysis →

Yahoo Finance 70% confidence